Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANCN
DateTimeSourceHeadlineSymbolCompany
16/06/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
05/06/202312:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
19/05/202321:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
11/05/202311:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202311:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202311:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202311:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
22/03/202320:46Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
21/02/202312:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
21/02/202311:20Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
11/01/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
05/01/202321:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
05/01/202321:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
03/01/202312:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/11/202211:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/11/202212:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
17/11/202221:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
16/11/202212:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/11/202221:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANCNAnchiano Therapeutics Ltd
14/11/202221:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
10/11/202221:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/08/202221:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANCNAnchiano Therapeutics Ltd
12/08/202212:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
21/06/202212:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
08/06/202211:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
31/05/202215:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/05/202221:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
19/05/202221:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
12/05/202211:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
28/04/202221:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ANCN